DTC (Direct to Consumer) DNA Test Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

DTC (Direct to Consumer) DNA Test Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The DTC (Direct to Consumer) DNA test kits market is expected to register a CAGR of 15.70% over the forecast period (2022-2027).

The outbreak of the pandemic imposed a positive impact on the DTC (Direct to Consumer) DNA test kits market. Biopharmaceutical innovators are at the forefront of the human response to the COVID-19 pandemic. A significant number of major biotech firms are in a race to investigate the Sars-Cov-2 genome and prepare rapid testing for the same. As compared to the speed of response to SARS/MERs, etc. biotech entities are investigating in SARs-Cov-2 at an unprecedented rate, and a considerable amount of funds are being utilized for R&D activities. With multiple candidates in the trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a cure is developed for COVID-19. Genetic testing helps to identify variations that affect the response to COVID-19 and discover new therapies that could reduce harm, save lives, and even prevent future outbreaks. Thus, the demand for genetic testing has experienced sudden spikes due to the pandemic. In addition, the advantages of DTC DNA testing have positively impacted the market during COVID-19. Some of the major advantages include increasing access to testing at home that reduces the risk of exposure to the virus for consumers and medical personnel, and thereby reducing the risk of spreading infection.

However, disruption in the supply chain during COVID-19 and delay in delivery of essential products required for manufacturing DTC DNA kits imposed an adverse effect on the DTC (Direct to Consumer) DNA test kits market. Some major issues faced by the market during a pandemic include trucking bottlenecks and port checkpoints slowing down their deliveries including critical supplies, export bans imposed in many countries with only a few manufacturing units being functional, and lack of healthcare workers to transport and produce products. Therefore, such a restraining factor imposed an adverse impact on the market initially, however, in later times the positive developments helped the market to gain positive momentum, thereby propelling the market growth.

Increasing demand for paternity testing across the globe especially in the European countries is anticipated to propel the market growth over the forecast period. For instance, in February 2022, AlphaBiolabs received UKAS accreditation for prenatal paternity testing in the United Kingdom for the first time. In addition, as per the journal published by the AlphaBiolabs in February 2022, the demand for prenatal paternity testing surged by 47.0% in 2021 versus pre-pandemic days. Therefore, such factors indicate increase in the demand of DTC (Direct to Consumer) DNA test kits, thereby propelling the market growth over the forecast period.

However, regulatory challenges pertaining to the use of DTC genetic tests are likely to impede the market growth over the forecast period.

Key Market TrendsAncestry Testing Segment is Expected to Witness Growth Over the Forecast Period

An ancestry test is a DTC DNA-based test that reads specific locations of a subject’s genome, to find or validate ancestral hereditary relationships or to evaluate the ethnic combination of an individual. The increasing number of people who are interested in knowing their ancestors and family trees is increasing the demand for DTC DNA test kits, especially in developing countries. The ancestry testing entails comparing the frequencies of many DNA variants found in an individual with those found in reference populations drawn from all over the world. In addition, ancestry testing is also performed to identify the carrier of any hereditary diseases or conditions such as polycystic kidney disease, breast cancer, Alzheimer’s disease, various inborn errors of metabolism, and cystic fibrosis.

The increasing demand for ancestry testing across the globe is one of the major factors propelling the segment growth over the forecast period. For instance, as per the study published by the National Library of Medicine in March 2020, more than 26.0 million people have taken at-home ancestry tests across the globe in February 2020.

Therefore, considering the above mentioned factors, the ancestry testing segment is expected to witness significant growth over the forecast period.

North America is Expected to Dominate the DTC (Direct to Consumer) DNA Test Kits Market Over the Forecast Period

The growth of the market in North America is majorly due to the rising prevalence of congenital anomalies. For instance, as per the report published by the Centers for Disease Control and Prevention in 2021, one in every 33 babies in the United States are born with birth defects every year. In the North America region, the United States is expected to witness the largest market share owing to the factors such as easy acceptance of such kits in the country and high disposable income.

Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players in the United States are some of the factors driving the growth of the DTC (Direct to Consumer) DNA test kits market in the country. For instance, in August 2020, Ancestry launched AncestryHealth equipped with Next Generation Sequencing (NGS), which offers comprehensive data on common inherited health conditions. It is designed to help people to understand their risk of developing certain inheritable health conditions. Such continuous product launches are anticipated to drive the growth of the market in the country.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The DTC (Direct to Consumer) DNA test kits market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Ancestry.com LLC, 23andMe, MyHeritage Ltd., Gene by Gene, Living DNA Ltd., Helix OpCo, LLC., Veritas Genetics, Futura Genetics, Mapmygenome, Genesis Healthcare Co., Pathway genomics, and Identigene among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.